How Boosting a Single Protein Made Old Mice Act Younger
Key takeaways
-
Boosting a single inflammation‑controlling protein called tristetraprolin (TTP) made older mice stronger, more mobile, and less frail.
-
Mice with higher TTP had better grip strength, walking speed, endurance, bone health, and a more “youthful” immune profile.
-
TTP helps break down inflammatory signals before they accumulate, suggesting that dialing down “inflammaging” could support healthier aging—but human treatments are still a long way off.
As people get older, the immune system often shifts into a low‑grade, chronic inflammatory state sometimes described as “inflammaging.” This background smoldering inflammation can wear down tissues and is tied to weaker immunity, bone loss, and physical decline.
Researchers at the University at Buffalo focused on tristetraprolin (TTP), an RNA‑binding protein that normally helps keep inflammation in check by targeting pro‑inflammatory messages (mRNAs) for rapid breakdown. Levels of TTP naturally fall with age, especially in immune cells, which may allow inflammatory molecules to linger longer than they should.
What happened when scientists boosted TTP
To test whether shoring up this protein could change how aging looks and feels in the body, the team genetically modified elderly mice—around 22 months old—to maintain higher TTP levels. They then measured frailty through several physical tests, including grip strength, walking speed, treadmill endurance, and overall energy.
Male mice with increased TTP had noticeably lower frailty scores than unmodified peers. They showed stronger grip, smoother walking, better endurance, and improved overall performance. Their bones also looked healthier, with less breakdown, and their immune profile appeared more “youthful” compared with typical age‑matched animals. Female mice also benefited, though their improvements were smaller, possibly due to factors like smaller body size and shifting hormone levels.
Why this matters for healthy aging
The results suggest that maintaining stronger TTP activity can help dial down age‑related inflammation and support better physical function, at least in mice. By speeding the decay of pro‑inflammatory signals, TTP seems to protect bone and muscle, helping older animals stay stronger and more resilient.
The researchers see this as an encouraging proof‑of‑concept that targeting key inflammation regulators might one day help people age with better mobility and independence. However, they emphasize that this is early, preclinical work. Although some initial efforts have screened for compounds that raise TTP levels, no clear drug candidates are ready for humans yet, and any eventual therapy would need to balance reducing harmful inflammation with preserving normal immune defenses.
What’s next for TTP research
The team is now exploring whether enhancing TTP can also calm inflammation in the brain, which may be relevant to age‑related cognitive decline. Future studies will likely probe how TTP interacts with bone cells, immune cells, and the nervous system, and whether non‑genetic approaches—such as small molecules—can safely nudge TTP upward.
For now, the work highlights an important principle: how the body manages inflammatory messages over time can shape strength, bone integrity, and overall resilience in later life. While TTP‑based treatments are not on the near‑term horizon, understanding this pathway could eventually inspire new strategies to support healthy aging alongside lifestyle foundations like movement, nutrition, sleep, and social connection.
References:
- Ramkumar Thiyagarajan, Lixia Zhang, Leticia Andrea Rojas Cortez, Kyu Hwan Kwack, Victoria Maglaras, Nanda Kumar Yellapu, Yukitomo Arao, Kenneth L. Seldeen, Perry J. Blackshear, Bruce R. Troen, Keith L. Kirkwood. Increased Stability of Tristetraprolin mRNA Supports Bone Health and Decreases Frailty During Aging. Aging and Disease, 13 January 2026 DOI: 10.14336/AD.2025.1243